[PDF][PDF] Advances and Challenges in Closed Loop Therapeutics: From Signal Selection to Optogenetic Techniques
F Pedro - Journal of Biomedical and Sustainable Healthcare …, 2024 - anapub.co.ke
The main objective of this paper is to develop closed-loop therapeutic systems by reviewing
various neurological disorders. We propose a system that incorporates a biosensor …
various neurological disorders. We propose a system that incorporates a biosensor …
Targeted cancer therapy using compounds activated by light
Simple Summary Cancer is among the leading causes of death, and cancer therapy suffers
from many drawbacks, the lack of selectivity being most noteworthy. In this review, we …
from many drawbacks, the lack of selectivity being most noteworthy. In this review, we …
Photoswitchable inhibitors of microtubule dynamics optically control mitosis and cell death
M Borowiak, W Nahaboo, M Reynders, K Nekolla… - Cell, 2015 - cell.com
Small molecules that interfere with microtubule dynamics, such as Taxol and the Vinca
alkaloids, are widely used in cell biology research and as clinical anticancer drugs …
alkaloids, are widely used in cell biology research and as clinical anticancer drugs …
Light-triggered switching of liposome surface charge directs delivery of membrane impermeable payloads in vivo
G Arias-Alpizar, L Kong, RC Vlieg, A Rabe… - Nature …, 2020 - nature.com
Surface charge plays a fundamental role in determining the fate of a nanoparticle, and any
encapsulated contents, in vivo. Herein, we describe, and visualise in real time, light …
encapsulated contents, in vivo. Herein, we describe, and visualise in real time, light …
Beyond photodynamic therapy: light-activated cancer chemotherapy
F Reeæ# 159; ing, W Szymanski - Current Medicinal Chemistry, 2017 - benthamdirect.com
Background: Cancer chemotherapy is limited by severe side effects due to unspecific
cytotoxic activity of currently used therapeutics. In order to minimize these unwanted effects …
cytotoxic activity of currently used therapeutics. In order to minimize these unwanted effects …
Nuclear targeting with an Auger electron emitter potentiates the action of a widely used antineoplastic drug
S Imstepf, V Pierroz, P Raposinho… - Bioconjugate …, 2015 - ACS Publications
We present the combination of the clinically well-proven chemotherapeutic agent,
Doxorubicin, and 99mTc, an Auger and internal conversion electron emitter, into a dual …
Doxorubicin, and 99mTc, an Auger and internal conversion electron emitter, into a dual …
[HTML][HTML] Site-specific antibody masking enables conditional activation with different stimuli
Antibody therapeutics show great potential to treat a variety of diseases. Often, the dose that
can be safely administered is limited by side effects that arise from the interaction with the …
can be safely administered is limited by side effects that arise from the interaction with the …
[HTML][HTML] Synthesis and preliminary anticancer evaluation of photo-responsive prodrugs of hydroxymethylene bisphosphonate alendronate
A Descamps, P Arnoux, C Frochot, F Barbault… - European Journal of …, 2024 - Elsevier
The antitumoral activity of hydroxymethylene bisphosphonates (HMBP) such as alendronate
or zoledronate is hampered by their exceptional bone-binding properties and their short …
or zoledronate is hampered by their exceptional bone-binding properties and their short …
Synthesis and Investigations of Building Blocks with Dibenzo[b,f] Oxepine for Use in Photopharmacology
P Tobiasz, F Borys, M Borecka, H Krawczyk - International Journal of …, 2021 - mdpi.com
The synthesis of photoswitchable azo-dibenzo [b, f] oxepine derivatives and microtubule
inhibitors were described. Subsequently, we examined the reaction of methoxy derivative 3 …
inhibitors were described. Subsequently, we examined the reaction of methoxy derivative 3 …
Chronic activation of the D156A point mutant of Channelrhodopsin-2 signals apoptotic cell death: the good and the bad
M Perny, L Muri, H Dawson, S Kleinlogel - Cell death & disease, 2016 - nature.com
Abstract Channelrhodopsin-2 (ChR2) has become a celebrated research tool and is
considered a promising potential therapeutic for neurological disorders. While making its …
considered a promising potential therapeutic for neurological disorders. While making its …